Výsledky vyhledávání - "S Diane, Goodwin"

Impact of an Educational Program on Efficacy and Adherence With a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients

Autor: Jerry M. Tolson, S. Diane Goodwin, Karen H. Crawford, Mark S. Shaefer, Melanie A. Thompson, Charles Farthing, Joseph Racine, M. Keith Rawlings, Robert C. Scott, Vanessa C. Williams, Lawrence S. Brown

Publikováno v: JAIDS Journal of Acquired Immune Deficiency Syndromes. 34:174-183

A 24-week open-label clinical trial was conducted in 195 HIV-infected adults commonly underrepresented in research (35% female, 71% African American, 21% Hispanic, and 20% injection drug users [IDUs]) to evaluate the effect of an HIV educational prog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47684976490d611502040e5f876209a
https://doi.org/10.1097/00126334-200310010-00007

Zobrazit plný text záznamu

Once‐Daily Quadruple‐Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment‐Naive Human Immunodeficiency Virus Type 1–Infected Patients

Autor: Gail, Skowron, Daniel R, Kuritzkes, Melanie A, Thompson, Kathleen E, Squires, S Diane, Goodwin, Betsy A, Dusak, Jerry M, Tolson, Michael, Stevens, Geoffrey J, Yuen, James F, Rooney

Publikováno v: The Journal of Infectious Diseases. 186:1028-1033

A 48-week open-label study of 11 antiretroviral-naive, human immunodeficiency virus type 1 (HIV-1)-infected adults evaluated once-daily treatment with adefovir dipivoxil, lamivudine, didanosine, and efavirenz. At baseline, the median plasma HIV-1 RNA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d97d76242bbb4a4018bced2047afb7f
https://doi.org/10.1086/343740

Zobrazit plný text záznamu

Pharmacotherapy of Disseminated Histoplasmosis in Patients with AIDS

Autor: S. Diane Goodwin, Courtney V. Fletcher, Richard H. Drew

Publikováno v: Annals of Pharmacotherapy. 27:1510-1518

OBJECTIVE:To review the pharmacotherapy of disseminated histoplasmosis (DH) in patients with AIDS. The article provides an overview of the pathophysiology, epidemiology, clinical presentation and diagnosis of this disease. Clinical trials reporting i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4978d3c833aba4146b5137872532ccb2
https://doi.org/10.1177/106002809302701218

Zobrazit plný text záznamu

Zalcitabine

Autor: S. Diane Goodwin, Courtney V. Fletcher, Mark J. Shelton, Alice M. O'Donnell, Gene D. Morse

Publikováno v: Annals of Pharmacotherapy. 27:480-489

OBJECTIVE:To review the chemistry, intracellular metabolism, pharmacokinetics, and clinical trials of zalcitabine (2',3'-dideoxycytidine, ddC).DATA SOURCES:English-language articles and conference proceedings. The indexing terms used were zalcitabine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572073f1959e2a0abd03dabac5756311
https://doi.org/10.1177/106002809302700416

Zobrazit plný text záznamu

Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia. Review of the literature and Food and Drug Administration Adverse Drug Reaction reports

Autor: Robb W. Glenny, S. Diane Goodwin

Publikováno v: Archives of Internal Medicine. 152:1521-1524

Objective.— The purpose of this study was to detail the clinical and pathologic presentation of pulmonary infiltrates with eosinophilia (PIE) associated with nonsteroidal anti-inflammatory drug use. Methods. — We reviewed case reports and Food an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd865db51892792a15e8da8b67bec857
https://doi.org/10.1001/archinte.152.7.1521

Zobrazit plný text záznamu

Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients

Autor: Judy Johnson, Gladys E. Sepulveda, Jorge Santana, Nicholaos C. Bellos, Michael Sension, S. Diane Goodwin, Michael H. Ames, Edwin DeJesus

Publikováno v: HIV clinical trials. 3(5)

To compare the efficacy (sustained virologic suppression) and safety/tolerability of a switch to lamivudine 300 mg once daily (QD) versus continued lamivudine 150 mg twice daily (BID) in virologically suppressed patients (HIV-1 RNA400 copies/mL foror

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ebd710debe2b7ec94dfa0aab373d63
https://pubmed.ncbi.nlm.nih.gov/12407485

Zobrazit plný text záznamu

Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole

Autor: Mary T. Pasko, Cynthia A. Walawander, S. Diane Goodwin, Marsha A. Raebel, Thaddeus H. Grasela

Publikováno v: The Annals of pharmacotherapy. 28(2)

OBJECTIVE: To evaluate the use of antifungal agents in hospitalized patients prior to marketing of fluconazole and to assess characteristics associated with their use. DESIGN: A cohort of hospitalized patients receiving topical or systemic antifungal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::055bd05355d3aca64bf9c950cd7cc3cd
https://pubmed.ncbi.nlm.nih.gov/8173147

Zobrazit plný text záznamu

Rewards and Advancements for Clinical Pharmacists

Autor: Sandra L. Kane-Gill, Mary M. Hess, Joel T Melroy, Toby C. Trujillo, Kimberly Tallian, Tien M H Ng, S Diane Goodwin, Lee C. Vermeulen

Publikováno v: Pharmacotherapy. 30:114-114

The American College of Clinical Pharmacy charged the Clinical Practice Affairs Committee to review and update the College's 1995 White Paper, "Rewards and Advancements for Clinical Pharmacy Practitioners." Because of the limited data on the present

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::178aea7756db004db1ef921214dfad49
https://doi.org/10.1592/phco.30.1.114

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání